HUP0600302A2 - C10 ester substituted taxanes as antitumor agents - Google Patents

C10 ester substituted taxanes as antitumor agents

Info

Publication number
HUP0600302A2
HUP0600302A2 HU0600302A HUP0600302A HUP0600302A2 HU P0600302 A2 HUP0600302 A2 HU P0600302A2 HU 0600302 A HU0600302 A HU 0600302A HU P0600302 A HUP0600302 A HU P0600302A HU P0600302 A2 HUP0600302 A2 HU P0600302A2
Authority
HU
Hungary
Prior art keywords
antitumor agents
ester substituted
substituted taxanes
taxanes
ester
Prior art date
Application number
HU0600302A
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of HUP0600302A2 publication Critical patent/HUP0600302A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/75Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0600302A 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents HUP0600302A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02
PCT/US2001/003623 WO2001057032A1 (en) 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
HUP0600302A2 true HUP0600302A2 (en) 2006-07-28

Family

ID=22657972

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0600302A HUP0600302A2 (en) 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents

Country Status (25)

Country Link
EP (1) EP1165553B1 (hu)
JP (1) JP2003522172A (hu)
CN (1) CN1380882A (hu)
AT (1) ATE432928T1 (hu)
AU (1) AU782150B2 (hu)
BG (1) BG64889B1 (hu)
BR (1) BR0104354A (hu)
CA (1) CA2368274C (hu)
CZ (1) CZ20013430A3 (hu)
DE (1) DE60138853D1 (hu)
GE (1) GEP20043323B (hu)
HU (1) HUP0600302A2 (hu)
IL (1) IL145638A (hu)
MX (1) MXPA01009905A (hu)
NO (1) NO327910B1 (hu)
NZ (1) NZ514382A (hu)
PL (1) PL202957B1 (hu)
RO (1) RO121270B1 (hu)
RU (1) RU2262506C2 (hu)
SK (1) SK13692001A3 (hu)
TR (1) TR200102858T1 (hu)
TW (1) TWI299732B (hu)
UA (1) UA75039C2 (hu)
WO (1) WO2001057032A1 (hu)
ZA (1) ZA200108055B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
HN2005000054A (es) 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
MX2007009748A (es) * 2005-02-14 2007-09-26 Univ Florida State Res Found Composiciones de taxano sustituidas con esteres ciclopropilicos en c10.
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
EP0690711B1 (en) * 1993-03-22 2000-08-16 Florida State University Taxanes having an amino substituted side-chain
EP0690712B1 (en) * 1993-03-22 2001-11-28 Florida State University Taxanes having a pyridyl substituted side-chain
PT1228759E (pt) * 1993-03-22 2005-04-29 Univ Florida State Composicoes farmaceuticas contendo um taxano possuindo uma cadeia lateral substituida com furilo ou tienilo
AU4133096A (en) * 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
DK0914116T3 (da) * 1996-05-22 2000-11-20 Protarga Inc Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere
CA2314071A1 (en) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Taxane derivatives
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
IL145638A (en) 2011-05-31
ZA200108055B (en) 2003-12-01
NO20014754D0 (no) 2001-10-01
EP1165553B1 (en) 2009-06-03
AU3480901A (en) 2001-08-14
DE60138853D1 (de) 2009-07-16
UA75039C2 (en) 2006-03-15
MXPA01009905A (es) 2003-08-20
NZ514382A (en) 2004-05-28
BG105965A (en) 2002-07-31
IL145638A0 (en) 2002-06-30
BR0104354A (pt) 2002-01-02
NO20014754L (no) 2001-11-29
RO121270B1 (ro) 2007-02-28
GEP20043323B (en) 2004-02-10
WO2001057032A1 (en) 2001-08-09
PL202957B1 (pl) 2009-08-31
JP2003522172A (ja) 2003-07-22
CA2368274C (en) 2009-10-13
NO327910B1 (no) 2009-10-19
AU782150B2 (en) 2005-07-07
EP1165553A1 (en) 2002-01-02
TR200102858T1 (tr) 2002-12-23
RU2262506C2 (ru) 2005-10-20
CA2368274A1 (en) 2001-08-09
BG64889B1 (bg) 2006-08-31
ATE432928T1 (de) 2009-06-15
PL351380A1 (en) 2003-04-07
CN1380882A (zh) 2002-11-20
TWI299732B (en) 2008-08-11
SK13692001A3 (sk) 2002-07-02
CZ20013430A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
HU0200917D0 (en) C7 ester substituted taxanes as antitumor agents
PL360027A1 (en) Substituted-triazolopyrimidines as anticancer agents
HK1057895A1 (en) Polyarylcarboxamides useful as lipid lowering agents
HK1073310A1 (en) Biphenylcarboxamides useful as lipid lowering agents
NZ514074A (en) C10 carbonate substituted taxanes as antitumor agents
HUP0600302A2 (en) C10 ester substituted taxanes as antitumor agents
PL350315A1 (en) C7 carbonate substituted taxanes as antitumor agents
HK1061978A1 (en) Lipid peroxide-lowering compositions
HUP0200752A3 (en) C7 carbamoyloxy substituted taxanes as antitumor agents
SG129990A1 (en) C10 ester substituted taxanes
HU0103245D0 (en) C10 ester substituted taxanes
ZA200106333B (en) C10 ester substituted taxanes.
HUP0103247A3 (en) C7 ester substituted taxanes
ZA200106335B (en) C7 ester substituted taxanes.
HUP0103246A3 (en) C10 carbonate substituted taxanes
GB0015865D0 (en) Lipid compositions

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees